Heart Attack Diagnostics Market revenue to cross USD 28 Billion by 2033, says Research Nester
23 janv. 2024 07h00 HE
|
Research Nester
New York , Jan. 23, 2024 (GLOBE NEWSWIRE) -- The global heart attack diagnostics market size is estimated to attain at 8% CAGR from 2023 to 2033. The market is expected to garner a revenue of USD 28...
CLS Americas Selects Quest International to Provide Aftermarket Service and Logistics Operations for TRANBERG Laser Ablation System
28 nov. 2023 07h00 HE
|
Clinical Laserthermia Systems Americas, Inc.
CLS Americas selects Quest International, a global aftermarket technical service provider to OEMs, to provide Service and Logistics to the US market.
Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids Reaches Patient Milestones in the U.S. and Globally
17 oct. 2023 12h00 HE
|
Gynesonics
Gynesonics' Sonata® Procedure has been used to treat over 1,000 women in the United States and approximately 6,500 women globally.
Global Deflectable Catheters Market Size is Poised to Exceed $15.1 Billion by 2030, Witness 5.3% CAGR
24 août 2023 14h19 HE
|
Zion Market Research
New York, NY, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Deflectable Catheters Market By Product (Uni-Directional Deflectable Catheters,...
How Will the Minimally Invasive Surgical Instruments Market Transform Itself into a USD 60.64 Billion Powerhouse by 2030?
14 août 2023 12h00 HE
|
Emergen Research
Vancouver, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Emergen research is one of the pioneers in providing strategic insights for emerging and disruptive technologies which are supposed to show exponential...
ImPact Biotech Announces Research Collaboration to develop a treatment to arrest Pathologic Myopia using its Padeliporfin minimally invasive platform
13 août 2023 16h16 HE
|
ImPact Biotech
ImPact Biotech to collaborate with Maastricht University researchers to develop a treatment to arrest the progressive condition Pathologic Myopia, a leading cause of irreversible sight impairment and...
ImPact Biotech receives FDA Clearance for Padeliporfin VTP Phase 1 Clinical Program in Peripheral Lung Cancer
04 août 2023 10h49 HE
|
ImPact Biotech
Padeliporfin VTP Phase 1 trial in Peripheral Non-Small Cell Lung Cancer to start by end Q4 2023 TEL AVIV, Israel, Aug. 04, 2023 (GLOBE NEWSWIRE) -- ImPact Biotech,...
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
13 juil. 2023 16h30 HE
|
Globus Medical
AUDUBON, Pa., July 13, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June...
Global Extreme Lateral Interbody Fusion (XLIF) Surgery Market Size Is Anticipated to Grow at 4.52% CAGR, Achieving $1.4 Billion by 2030
07 juil. 2023 14h21 HE
|
Zion Market Research
Houston, TX, July 07, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Extreme Lateral Interbody Fusion (XLIF) Surgery Market By End-User (Spinal Surgery...
ImPact Biotech receives FDA Orphan Drug Designation for Padeliporfin VTP in Pancreatic Cancer
05 juil. 2023 09h44 HE
|
ImPact Biotech
Designation confers advantages including marketing exclusivity and tax credits Padeliporfin VTP Phase 1 trial in Pancreatic cancer to start by end Q4 2023 TEL AVIV, Israel, July 05, 2023 (GLOBE...